Connor Clark & Lunn Investment Management Ltd. Sells 3,079 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

Connor Clark & Lunn Investment Management Ltd. cut its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 1.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 268,806 shares of the company’s stock after selling 3,079 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned 0.54% of Nu Skin Enterprises worth $1,852,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Quest Partners LLC purchased a new position in shares of Nu Skin Enterprises in the 3rd quarter worth about $268,000. LMR Partners LLP bought a new stake in shares of Nu Skin Enterprises during the 3rd quarter valued at about $182,000. Intech Investment Management LLC purchased a new position in shares of Nu Skin Enterprises during the 3rd quarter valued at about $138,000. Dynamic Technology Lab Private Ltd increased its stake in Nu Skin Enterprises by 264.3% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 142,563 shares of the company’s stock worth $1,050,000 after purchasing an additional 103,432 shares during the period. Finally, DRW Securities LLC purchased a new position in Nu Skin Enterprises in the 3rd quarter worth approximately $305,000. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Price Performance

Shares of Nu Skin Enterprises stock opened at $8.03 on Wednesday. The stock has a 50 day moving average of $7.25 and a 200 day moving average of $7.11. Nu Skin Enterprises, Inc. has a 12 month low of $5.95 and a 12 month high of $14.04. The firm has a market cap of $399.47 million, a PE ratio of -2.72 and a beta of 1.06. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.14. The firm had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. On average, research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were paid a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a yield of 2.99%. Nu Skin Enterprises’s dividend payout ratio (DPR) is -8.14%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on NUS shares. DA Davidson dropped their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Tuesday, February 25th.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.